This resource may include information that has not been approved by the US Food and Drug Administration. For full prescribing information, including. Fosphenytoin official prescribing information for healthcare professionals. Includes: indications, dosage, adverse reactions, pharmacology and more. Medscape – Epilepsy dosing for Cerebyx (fosphenytoin), frequency-based adverse contraindications, pregnancy & lactation schedules, and cost information. be expressed as phenytoin sodium equivalents (PE) when prescribing; There is.

Author: Julabar Goltinos
Country: Armenia
Language: English (Spanish)
Genre: Environment
Published (Last): 6 August 2009
Pages: 155
PDF File Size: 12.90 Mb
ePub File Size: 12.20 Mb
ISBN: 875-2-26129-838-1
Downloads: 58338
Price: Free* [*Free Regsitration Required]
Uploader: Taukus

Cariprazine The metabolism of Fosphenytoin can be decreased when combined with Cariprazine. Alcohol Use Acute alcohol intake may increase plasma phenytoin concentrations while chronic alcohol use may decrease plasma phenytoin concentrations. Hypotension can occur when either drug is administered rapidly by the IV route. Enflurane The risk or severity of adverse effects can be increased when Enflurane is combined with Fosphenytoin.

Pro-Epanutin Concentrate for Infusion / Solution for Injection

Fesoterodine The metabolism of Fosphenytoin can be decreased when combined with Fesoterodine. Since fosphenytoin is a prodrug of phenytoin, the carcinogenicity results with phenytoin can presctibing extrapolated. Levopropoxyphene The therapeutic efficacy of Fosphenytoin can be decreased when used in combination with Levopropoxyphene.

Large amounts of phosphate, delivered rapidly, could potentially cause fosphneytoin with paraesthesia, muscle spasms and seizures. Package contains 10 vials of NDC With two exceptions, these events are commonly associated with the administration of IV phenytoin. Canagliflozin The serum concentration of Canagliflozin can be decreased when it is combined with Fosphenytoin.

  GYMNASIEKEMI A PDF

Fksphenytoin The metabolism of Fosphenytoin can be decreased when combined with Cabergoline. Some of these events have informatlon fatal or life threatening. The effect of age on the pharmacokinetics of fosphenytoin was evaluated in patients 5 to 98 years of age. Phenytoin or Fosphenytoin Sodium Injection is a potent inducer of hepatic drug-metabolizing enzymes. Lomustine The metabolism of Fosphenytoin can be decreased when combined with Lomustine.

The study demonstrated better local tolerance pain and burning at the infusion sitefewer disruptions of the infusion, and a shorter infusion period for CEREBYX-treated patients Table 5.

Aceclofenac The metabolism of Fosphenytoin can be decreased when combined with Aceclofenac.

Entacapone The metabolism of Entacapone can be decreased when combined with Fosphenytoin. Metamizole The metabolism of Fosphenytoin can be increased when combined with Metamizole. Diazepam The metabolism of Fosphenytoin can be decreased when combined with Diazepam.

Carcinogenicity studies with fosphenytoin are unavailable. Cinitapride The risk or severity of adverse effects can be increased when Fosphenytoin onformation combined with Cinitapride. HPLC accurately quantitate phenytoin concentrations in biological fluids in the presence of fosphenytoin.

Fosphenytoin – FDA prescribing information, side effects and uses

Advise women of childbearing potential who are not planning a pregnancy to use effective contraception while using CEREBYX, keeping in mind that there is a potential for decreased hormonal contraceptive efficacy [see Drug Interactions 7. The pharmacological and toxicological effects of fosphenytoin sodium include those of phenytoin.

  CHASIN THE TRANE PDF

Ketanserin The risk or severity of adverse effects can be increased when Fosphenytoin is combined with Ketanserin. Amlodipine The metabolism of Fosphenytoin can ibformation decreased when combined with Amlodipine.

Frovatriptan The risk or severity of adverse effects can be increased when Frovatriptan is combined with Fosphenytoin. The adverse clinical events most commonly observed with the use of fosphenytoin in clinical trials were nystagmus, dizziness, pruritus, paraesthesia, headachesomnolence, and ataxia.

Imatinib The metabolism of Imatinib can be increased when combined with Fosphenytoin. The mechanism of fosphenytoin conversion has not been determined but phosphatases probably play a major role. Bisoprolol The metabolism of Fosphenytoin can be decreased when combined with Bisoprolol. Famciclovir The metabolism of Fosphenytoin can be decreased when combined with Prescrlbing. Advise the patient that, because these signs and symptoms may signal a serious reaction, that they must report any occurrence immediately to a physician.